Author: Luis Soler Rivera
UVA Health Researcher Brings Clarity to Status Epilepticus Interventions
UVA Health research sheds light on the best second-line treatment for status epilepticus, a neurological emergency that can cause brain damage or even death.
UVA Health Genetic Research Lays Groundwork for Future Stroke Care
An international UVA Health research partnership with the ISGC has uncovered previously unknown genetic mechanisms related to stroke risk. These studies underline UVA Health's commitment to prevent stroke and improve treatment.
UVA Health Uncovers Genetic Components of Type 1 Diabetes That Could Lead to New Screening Guidelines
Over the past 2 decades, a UVA researcher has found new sites in the genome related to type 1 diabetes that could revolutionize screening and therapy.
Prozac Could Slow Progression of Macular Degeneration, Groundbreaking UVA Health Research Reveals
UVA Health’s groundbreaking research finds strong evidence fluoxetine could help slow or prevent the leading cause of blindness in older adults, age-related dry macular degeneration.
How High-Tech Robotics Can Improve Knee Replacement Success
Combining robust expertise with the latest robotics improves outcomes and reduces knee replacement revisions.
Expanding on the Promise of Less-Invasive Cancer Care with Focused Ultrasound
UVA Health continues to improve the lives of cancer patients with two new focused ultrasound clinical trials for bolstering treatment and pain palliation.